• Wed, December 13, 2017
  • Tue, December 12, 2017

Rohit Vanjani Initiated (TEVA) at Hold and Held Target at $16 on, Dec 12th, 2017

Rohit Vanjani of Guggenheim, Initiated "Teva Pharmaceutical Industries Limited" (TEVA) at Hold and Held Target at $16 on, Dec 12th, 2017.

Rohit has made no other calls on TEVA in the last 4 months.



There are 7 other peers that have a rating on TEVA. Out of the 7 peers that are also analyzing TEVA, 3 agree with Rohit's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Liav Abraham of "Citigroup" Maintained at Hold with Decreased Target to $13 on, Monday, November 13th, 2017
  • Gregg Gilbert of "Deutsche Bank" Downgraded from Strong Buy to Hold on, Friday, November 3rd, 2017
  • Douglas Tsao of "Barclays" Maintained at Hold with Decreased Target to $19 on, Friday, October 20th, 2017


These are the ratings of the 4 analyists that currently disagree with Rohit


  • Chris Schott of "JP Morgan" Downgraded from Hold to Sell on, Monday, November 13th, 2017
  • Vamil Divan of "Credit Suisse" Maintained at Sell with Decreased Target to $8 on, Monday, November 6th, 2017
  • David Risinger of "Morgan Stanley" Maintained at Sell with Decreased Target to $7 on, Friday, November 3rd, 2017
  • Tim Chiang of "BTIG" Upgraded from Hold to Strong Buy and Held Target at $24 on, Monday, September 11th, 2017